Anti-breast cancer agents, quinolines, targeting gap junction

Medicinal Chemistry

Volumn 7, Issue 5, 2011, Pages 448-453

  Bernzweig, Julie ^a   Heiniger, Brian ^a   Prasain, Keshar ^a   Lu, Jianyu ^a   Hua, Duy H ^a   Nguyen, Thu A ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

6 methoxy 4 methyl 8 (4 quinolinylmethyl)amino 5 (3 trifluoromethylphenyloxy) quinoline; Anti cancer drugs; Breast cancer; Gap junctions; GJIC

Indexed keywords

6 METHOXY 4 METHYL 8 [(4 QUINOLINYLMETHYL)AMINO] 5 (3 TRIFLUOROMETHYLPHENYLOXY)QUINOLINE; ALPHA SURVIVIN; ANTINEOPLASTIC AGENT; PQ 15; QUINOLINE DERIVATIVE; SURVIVIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CARCINOGENESIS; CELL COMMUNICATION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; GAP JUNCTION; HOMEOSTASIS; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GAP JUNCTIONS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 80052003293     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340611796799131     Document Type: Article

References (21)

1. Topper, Y. J.; Freeman, C. S. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol. Rev., 1980, 60(4), 1049-1106.
2. Deome, K. B.; Faulkin, L. J., Jr.; Bern, H. A.; Blair, P. B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res., 1959, 19(5), 515-520.
3. Loewenstein, W. R.; Kanno, Y. Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature, 1966, 209(5029), 1248-1249.
4. Zhu, D.; Kidder, G. M.; Caveney, S.; Naus, C. C. Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc. Natl. Acad. Sci. USA. 1992, 89(21), 10218-10221.
5. Goldberg, G. S.; Martyn, K. D.; Lau, A. F. A connexin 43 antisense vector reduces the ability of normal cells to inhibit the foci formation of transformed cells. Mol. Carcinog. 1994, 11(2), 106-114.
6. Lampe, P. D.; Lau, A. F. The effects of connexin phosphorylation on gap junctional communication. Int. J. Biochem. Cell Biol., 2004, 36(7), 1171-1186. (Pubitemid 38515659)
7. Tomasetto, C.; Neveu, M. J.; Daley, J.; Horan, P. K.; Sager, R. Specificity of gap junction communication among human mammary cells and connexin transfectants in culture. J. Cell Biol., 1993, 122(1), 157-167. (Pubitemid 23188807)
8. Gakhar, G.; Schrempp, D.; Nguyen, T. A. Regulation of gap junctional intercellular communication by TCDD in HMEC and MCF-7 breast cancer cells. Toxicol. Appl. Pharmacol., 2008, 235(2), 171-181.
9. Kanczuga-Koda, L.; Sulkowski, S.; Tomaszewski, J.; Koda, M.; Sulkowska, M.; Przystupa, W.; Golaszewska, J.; Baltaziak, M. Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer. Oncol. Rep., 2005, 14(2), 325-329.
10. Laird, D. W.; Fistouris, P.; Batist, G.; Alpert, L.; Huynh, H. T.; Carystinos, G. D.; Alaoui-Jamali, M. A. Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res., 1999, 59(16), 4104-4110. (Pubitemid 29393585)
11. Lee, S. W.; Tomasetto, C.; Paul, D.; Keyomarsi, K.; Sager, R. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J. Cell Biol., 1992, 118(5), 1213-1221.
12. Hirschi, K. K.; Xu, C. E.; Tsukamoto, T.; Sager, R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ., 1996, 7(7), 861-870. (Pubitemid 26360725)
13. Huang, R. P.; Hossain, M. Z.; Huang, R.; Gano, J.; Fan, Y.; Boynton, A. L. Connexin 43 (cx43) enhances chemotherapyinduced apoptosis in human glioblastoma cells. Int. J. Cancer, 2001, 92(1), 130-138. (Pubitemid 32187042)
14. Gakhar, G.; Ohira, T.; Shi, A.; Hua, D. H.; Nguyen, T. A. Antitumor Effect of Substituted Quinolines in Breast Cancer Cells. Drug Dev. Res., 2008, 69, 526-534.
15. Na, H. K.; Wilson, M. R.; Kang, K. S.; Chang, C. C.; Grunberger, D.; Trosko, J. E. Restoration of gap junctional intercellular communication by caffeic acid phenethyl ester (CAPE) in a rastransformed rat liver epithelial cell line. Cancer Letters, 2000, 157(1), 31-38. (Pubitemid 30421228)
16. Trosko, J. E.; Chang, C. C. Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. Mut. Res., 2001, 480-481, 219-229. (Pubitemid 32744830)
17. Shi, A.; Nguyen, T. A.; Battina, S. K.; Rana, S.; Takemoto, D. J.; Chiang, P. K.; Hua, D. H. Synthesis and anti-breast cancer activities of substituted quinolines. Bioorg. Med. Chem. Lett., 2008, 18(11), 3364-3368. (Pubitemid 351728090)
18. Plobeck, N.; Delorme, D.; Wei, Z. Y.; Yang, H.; Zhou, F.; Schwarz, P.; Gawell, L.; Gagnon, H.; Pelcman, B.; Schmidt, R.; Yue, S. Y.; Walpole, C.; Brown, W.; Zhou, E.; Labarre, M.; Payza, K.; St-Onge, S.; Kamassah, A.; Morin, P. E.; Projean, D.; Ducharme, J.; Roberts, E. New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stability. J. Med. Chem., 2000, 43(21), 3878-3894.
19. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics, 2009. CA Cancer J. Clin., 2009, 59(4), 225-249.
20. Heiniger, B. G., G.; Prasain, K.; Hua, D. H.; Nguyen, T. A. Second Generation of Substituted Quinolines as Anti-Cancer Drugs for Breast Cancer. Anticancer Res., 2010, 30(10), 3927-3932.
21. Lampe, P. D.; TenBroek, E. M.; Burt, J. M.; Kurata, W. E.; Johnson, R. G.; Lau, A. F., Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J. Cell Biol., 2000, 149(7), 1503-1512. (Pubitemid 30437622)